Shutterstock
Written by: Adriano Leuzzi – Head of Process Development; Angelo Raggioli – Head of Technology Development, ReiThera.
Advancements and Challenges in Bioprocessing for Viral-Vector Gene Therapy Manufacturing
Adriano Leuzzi, Head of Process Development and Angelo Raggioli, Head of Technology Development at ReiThera explore the advancements and challenges in bioprocessing for viral-vector gene therapy manufacturing in our latest EPM Online insight.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.